免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料，僅供一般參考，不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

Prospective Multi-Center Trial for FemBloc Permanent Birth Control

NCT：NCT05977751 · RECRUITING

NCT IDNCT05977751
狀態RECRUITING
開始日期2023-10-31
SponsorFemasys Inc. (INDUSTRY)
First posted
Last updated

簡要摘要

Prospective, multi-center, international, unblinded, single-arm trial of subjects undergoing FemBloc followed by ultrasound confirmation test.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑